Neuropsychiatric Disease and Treatment,
Journal Year:
2023,
Volume and Issue:
Volume 19, P. 1985 - 1986
Published: Sept. 1, 2023
We
read
with
great
interest
the
letter
by
Li
et
al
regarding
role
of
acupuncture
and
moxibustion
in
treatment
long-term
effects
COVID-19.While
we
have
established
therapeutic
patterns
for
acute
COVID-19,
there
are
no
standard
strategies
manifestations,
which
extremely
variegated
include
numerous
neuropsychiatric
symptoms.
1,2The
high
prevalence
anxiety
or
depressive
symptoms
among
those
who
experienced
even
mild
infections
from
SARS-CoV-2
suggests
that
should
not
be
limited
to
pharmacological
but
involve
psychological
support.
3
It
is
worth
noting
traditional
Chinese
medicine
still
widely
recognized
Europe,
its
has
been
marginal
managing
COVID-19
pandemic
most
European
American
countries.Although
included
options
conditions
such
as
tension-type
headache,
migraine,
fibromyalgia,
4
long-COVID
yet
defined.Regarding
moxibustion,
lack
scientific
evidence
effectiveness
obtained
via
clinical
trials
prevents
diffusion
Europe
US.One
recent
scoping
reviews
5
pointed
out
their
possible
guidelines,
systematic
reviews,
trials,
observational
studies,
protocols.However,
recommendations
on
guidelines
consensuses
based
experts'
experience
opinions
lacked
details
operation
process,
determining
difficulty
developing
common
strategies.Nonetheless,
interventions
were
often
combined
other
methods
(as
Western
medicine,
etc.),
so,
reported,
results
may
exaggerate
moxibustion.
5Furthermore,
further
limitations
instance,
sample
sizes
randomized
controlled
frequently
used
subjective
outcomes
predict
ago
puncture
ie
self-reporting
questionnaires.
6
A
correct
approach
management
arguably
start
development
validation
biomarkers
contributing
making
an
accurate
diagnosis
serving
purpose
objectively
delineating
responses
treatment.
7While
effective
treatments
lacking,
certain
myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS)
like
pacing
specific
medications
promising.Low-dose
naltrexone
antihistamines
provide
relief,
while
BC007
targets
autoimmunity
anticoagulants
address
abnormal
clotting.Apheresis
supplements
(coenzyme
Q10,
d-ribose)
seem
offer
potential
benefits.Case
reports
studies
highlight
additional
options:
Paxlovid
ameliorate
symptoms,
sulodexide
reduces
severity
burden,
probiotics
show
effectiveness,
stellate
ganglion
block
appears
alleviate
dysautonomia,
Pycnogenol
improves
physiological
measures
quality
life.
The Journal of Immunology,
Journal Year:
2024,
Volume and Issue:
212(4), P. 505 - 512
Published: Feb. 5, 2024
As
COVID-19
continues,
an
increasing
number
of
patients
develop
long
COVID
symptoms
varying
in
severity
that
last
for
weeks,
months,
or
longer.
Symptoms
commonly
include
lingering
loss
smell
and
taste,
hearing
loss,
extreme
fatigue,
"brain
fog."
Still,
persistent
cardiovascular
respiratory
problems,
muscle
weakness,
neurologic
issues
have
also
been
documented.
A
major
problem
is
the
lack
clear
guidelines
diagnosing
COVID.
Although
some
studies
suggest
due
to
prolonged
inflammation
after
SARS-CoV-2
infection,
underlying
mechanisms
remain
unclear.
The
broad
range
COVID-19's
bodily
effects
responses
initial
viral
infection
are
poorly
understood.
This
workshop
brought
together
multidisciplinary
experts
showcase
discuss
latest
research
on
chronic
might
be
associated
with
sequelae
following
infection.
ABSTRACT
Background
The
COVID‐19
pandemic
has
left
an
indelible
mark
on
the
world,
with
mounting
evidence
suggesting
that
it
not
only
posed
acute
challenges
to
global
healthcare
systems
but
also
unveiled
a
complex
array
of
long‐term
consequences,
particularly
cognitive
impairment
(CI).
As
persistence
post‐COVID‐19
neurological
syndrome
could
evolve
into
next
public
health
crisis,
is
imperative
gain
better
understanding
intricate
pathophysiology
CI
in
patients
and
viable
treatment
strategies.
Methods
This
comprehensive
review
explores
management
across
phases
COVID‐19,
from
infection
Long‐COVID,
by
synthesizing
findings
clinical,
preclinical,
mechanistic
studies
identify
key
contributors
CI,
as
well
current
therapeutic
approaches.
Results
Key
mechanisms
contributing
include
persistent
neuroinflammation,
cerebrovascular
complications,
direct
neuronal
injury,
activation
kynurenine
pathway,
psychological
distress.
Both
pharmacological
interventions,
such
anti‐inflammatory
therapies
agents
targeting
neuroinflammatory
pathways,
non‐pharmacological
strategies,
including
rehabilitation,
show
promise
addressing
these
challenges.
Although
much
derived
preclinical
animal
studies,
provide
foundational
insights
potential
Conclusion
By
knowledge,
this
highlights
importance
COVID‐19‐related
offers
actionable
for
mitigation
recovery
community
continues
grapple
pandemic's
impact.
Journal of Integrative Neuroscience,
Journal Year:
2024,
Volume and Issue:
23(5)
Published: May 20, 2024
Background:
Long-Covid,
characterized
by
persistent
symptoms
following
acute
Covid-19
infection,
represents
a
complex
challenge
for
the
scientific
community.
Among
most
common
and
debilitating
manifestations,
cognitive
fog
is
neurological
disorder
mental
confusion
difficulties.
In
this
study,
we
investigated
long-term
effects
of
previous
infection
on
cortical
brain
activity
in
patients
experiencing
medium
long
term.
Methods:
A
total
40
subjects
(20
females
20
males)
aged
between
45
70
years
(mean
age
(M)
=
59.78,
standard
deviation
(SD)
12.93)
participated
study.
This
sample
included
individuals
with
fog,
both
without
anosmia,
control
group
comprised
healthy
subjects.
All
electroencephalography
(EEG)
data
were
collected
two
sessions,
1
month
8
months
after
recovery
from
Covid-19,
to
measure
neurophysiological
parameters
P300
beta
band
rhythms.
Results:
The
results
revealed
significant
differences
rhythms
affected
these
alterations
persist
even
Covid-19.
Interestingly,
no
observed
participants
anosmia
associated
fog.
Conclusions:
These
findings
provide
contribution
understanding
have
important
implications
future
interventions
aimed
at
managing
treating
symptoms.
longitudinal
assessment
helps
highlight
impact
virus
health
Long-Covid
patients.
Neurotrauma Reports,
Journal Year:
2024,
Volume and Issue:
5(1), P. 226 - 231
Published: March 1, 2024
Traumatic
Brain
Injury
(TBI)
is
a
significant
contributor
to
disability
across
the
world.
TBIs
vary
in
severity,
and
most
cases
are
designated
mild
TBI
(mTBI),
involving
only
brief
loss
of
consciousness
no
intracranial
findings
on
imaging.
Despite
this
categorization,
many
persons
continue
report
persistent
cognitive
changes
months
years
after
injury,
with
particular
impairment
executive
functions
pre-frontal
cortex.
For
these
persons,
there
currently
approved
medications,
treatment
limited
symptom
management
or
behavioral
therapy.
The
current
case
studies
explored
use
alpha-2A
adrenoreceptor
agonist,
guanfacine,
combined
antioxidant,
Neuropsychological Rehabilitation,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 17
Published: April 12, 2024
Background:
Cognitive
impairment,
brain
fog,
depressive
symptoms,
and
sleep
disturbance
are
prevalent
symptoms
among
individuals
with
long
COVID,
for
which
there
currently
is
no
treatment.
Aim:
To
assess
the
effectiveness
of
an
eight-week
cardiopulmonary
rehabilitation
programme
on
cognition,
psychological
well-being,
quality
in
COVID-19.
Methods:
Forty
participants
diagnosed
COVID-19
(26
female,
14
male
participants;
mean
age
53
±
11
years)
were
randomly
assigned
to
a
group
or
control
group.
The
maintained
their
regular
daily
habits,
while
was
prescribed
individualized
clinical
consisting
three
sessions
per
week.
Each
session
involved
light
moderate
aerobic
exercise,
resistance
training,
respiratory
exercises.
Neuropsychological
tests
evaluating
executive
function,
memory,
processing
speed
administered
at
baseline
study
completion.
Participants
also
completed
questionnaires
state
both
time
points.
Results:
No
difference
between
groups
observed
neuropsychological
test
performance,
however
significant
differences
perceived
stress
depression
found
post-intervention.
Conclusion:
Cardiopulmonary
shown
be
effective
suffering
from
COVID
terms
decreasing
levels
but
not
performance.
Aging Neuropsychology and Cognition,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 18
Published: April 16, 2024
We
investigated
the
association
between
pre-COVID-19
memory
function
and
(a)
receipt
of
a
COVID-19
test
(b)
incidence
using
Questionnaire
Study
(CQS)
Canadian
Longitudinal
on
Aging
(CLSA).
The
CQS
included
28,565
middle-aged
older
adults.
regressed
participants'
immediate
delayed
recall
scores
re-ran
regression
models
with
as
outcome.
All
were
adjusted
for
sociodemographic,
lifestyle,
health
covariates.
In
analytical
sample
(n
=
21,930),
higher
(better
memory)
was
significantly
associated
lower
incidence.
However,
this
not
significant
memory.
Immediate
test.
Health
policymakers
practitioners
may
viewmemory
status
potential
risk
COVID-19.
Memory
be
barrier
to
testing.
Archives of Clinical Neuropsychology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 23, 2024
The
global
impact
of
the
Coronavirus
Disease
(COVID-19)
pandemic
has
extended
beyond
physical
health,
leading
to
widespread
mental
health
issues.
Beyond
respiratory
symptoms,
there
is
a
growing
concern
about
long-term
cognitive
effects,
particularly
in
individuals
who
experienced
mild
cases
infection.
We
aimed
investigate
neuropsychological
aspects
COVID-19
non-hospitalized
adults
compared
with
control
group.
This
cross-sectional
study
included
42
participants,
22
history
COVID,
and
20
healthy
controls.
participants
were
recruited
from
community
underwent
comprehensive
assessment.
Participants
COVID
group
reported
symptoms
persisting
for
an
average
203.86
days
presented
higher
frequency
psychological
treatment
(81.8%)
(25.0%).
History
anxiety
disorders
was
more
prevalent
(63.6%)
than
(20.0%).
Significant
reductions
verbal
working
memory
observed
Levels
found
have
significant
on
difficulties
visual
recognition
memory.
reveals
important
alterations
following
COVID-19,
emphasizing
executive
functions
deficits.
Our
findings
underscore
persistence
these
deficits
even
cases,
suggesting
potential
inflammatory
mechanisms
central
nervous
system.
highlights
need
assessments
targeted
interventions
address
diverse
impacts
recovering
COVID-19.